Back to SYRE

UBS Group AG → SYRE

UBS Group AG SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
16
Latest value
$30K
Q3 2026
Peak value
$69.6M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$6.5M
Q3 2025$3K
Q4 2025$22.1M
Q4 2025$128K
Q4 2025$18K
Q1 2026$4K
Q1 2026$32.9M
Q1 2026$996K
Q2 2026$309K
Q2 2026$69.6M
Q2 2026$4.9M
Q2 2026$3K
Q3 2026$40K
Q3 2026$66.6M
Q3 2026$8.1M
Q3 2026$30K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$30K341——
Q3 2026$8.1M90.7K——
Q3 2026$66.6M748.5K——
Q3 2026$40K453——
Q2 2026$3K31——
Q2 2026$4.9M55.7K——
Q2 2026$69.6M783.9K——
Q2 2026$309K3.5K——
Q1 2026$996K19.8K——
Q1 2026$32.9M651.4K——
Q1 2026$4K87——
Q4 2025$18K543——
Q4 2025$128K3.9K——
Q4 2025$22.1M676.1K——
Q3 2025$3K176——
Q3 2025$6.5M385.4K——

Other funds holding SYRE

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B